Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

5.110 -0.160 (-3.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Where Fortrea Holdings Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Key Takeaways From Fortrea Holdings Analyst Ratings
Via Benzinga
Expert Outlook: Fortrea Holdings Through The Eyes Of 5 Analysts
Via Benzinga
Where Fortrea Holdings Stands With Analysts
Via Benzinga
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
Earnings Scheduled For March 11, 2024
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million. 
Via Benzinga
The Latest Analyst Ratings for Fortrea Holdings
Via Benzinga
Why Fortrea Holdings Shares Are Gaining Today
Activist hedge fund Starboard Value holds a  
Via Benzinga
Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024
Biotech stocks are often at the forefront of innovation. These picks are worth considering for your portfolio for their growth potential. 
Via InvestorPlace
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
Companies partner to provide patients and sites with easy access to study information in one integrated solution 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Previews J.P. Morgan Healthcare Conference Updates
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now. 
Via InvestorPlace
Fortrea Convenes New Site Advisory Board
Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships 
From Fortrea Holdings Inc
Via GlobeNewswire
Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?
Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in  
Via Benzinga
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies 
From Fortrea Holdings Inc
Via GlobeNewswire
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
The company's first quarter as a separate entity was better than anticipated. 
Via The Motley Fool
Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday
U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday. 
Via Benzinga
Topics Stocks
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Fortrea Reports Third Quarter 2023 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers 
From Fortrea Holdings Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback